当前位置: 首页 > 期刊 > 《医药产业资讯》 > 2018年第10期
编号:13230593
右美托咪定联合利多卡因静脉输注对腹腔镜全子宫切除术患者氧化应激水平及炎性反应的影响(4)
http://www.100md.com 2018年4月5日 《中国医药导报》 2018年第10期
     [15] Koca U,Olguner G,Ergür BU,et al. The effects of dexmedetomidine on secondary acute lung and kidney injuries in the rat model of intra-abdominal sepsis [J]. Scientific World Journal,2013,2013(4):292687.

    [16] Ramirez MF,Tran P,Cata JP. The Effect of Clinically Therapeutic Plasma Concentrations of Lidocaine on Natural Killer Cell Cytotoxicity [J]. Reg Anesth Pain Med,2015,40(1):43-48.

    [17] 房成,郭新玲,刘和平,等.不同麻醉药物对围术期食管癌根治术患者血清中细胞因子水平及血液流变学的影响及临床意义[J].中国医药导报,2012,9(31):90-91.

    [18] 尚穎,赵立元,陆景坤.炎性细胞因子与胃癌的关系[J].中国药科大学学报,2015,46(1):123-128.

    [19] 吕保来,吕继锋,郭珂清,等.利多卡因联合尼莫地平预防颅内动脉瘤术后脑血管痉挛的临床疗效观察[J].现代生物医学进展,2016,16(21):4124-4127.

    [20] Xu SQ,Li YH,Wang SB,et al. Effects of intravenous lidocaine,dexmedetomidine and their combination on postoperative pain and bowel function recovery after abdominal hysterectomy [J]. Minerva Anestesiol,2017,83(7):685.

    [21] Li B,Li Y,Tian S,et al. Anti-inflammatory Effects of Perioperative Dexmedetomidine Administered as an Adjunct to General Anesthesia:A Meta-analysis [J]. Sci Rep,2015,5:12342., http://www.100md.com(张努 徐连生)
上一页1 2 3 4